Paving the path to HIV neurotherapy: Predicting SIV CNS disease

European Journal of Pharmacology

Volumn 759, Issue , 2015, Pages 303-312

  Beck, Sarah E ^a   Queen, Suzanne E ^a   Witwer, Kenneth W ^a   Metcalf Pate, Kelly A ^a   Mangus, Lisa M ^a   Gama, Lucio ^a   Adams, Robert J ^a   Clements, Janice E ^a   Christine Zink, M ^a   Mankowski, Joseph L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CCL2; CSF; HIV; IL 6; MHC class I; Pigtailed macaque; Platelets; SIV

Indexed keywords

BIOLOGICAL MARKER; NEUROPROTECTIVE AGENT;

AIDS DEMENTIA COMPLEX; ANIMAL; BLOOD; CEREBROSPINAL FLUID; DISEASE MODEL; HUMAN; MACACA NEMESTRINA; PREDICTIVE VALUE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

AIDS DEMENTIA COMPLEX; ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; HUMANS; MACACA NEMESTRINA; NEUROPROTECTIVE AGENTS; PREDICTIVE VALUE OF TESTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84937758654     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.018     Document Type: Review

References (98)

1. T.M. Allen, J. Sidney, M.F. del Guercio, R.L. Glickman, G.L. Lensmeyer, D.A. Wiebe, R. DeMars, C.D. Pauza, R.P. Johnson, A. Sette, and D.I. Watkins Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A∗01) that binds an immunodominant CTL epitope from simianimmunodeficiency virus. J. Immunol 160 1998 6062 6071
2. A. Antinori, G. Arendt, J.T. Becker, B.J. Brew, D.A. Byrd, M. Cherner, D.B. Clifford, P. Cinque, L.G. Epstein, K. Goodkin, M. Gisslen, I. Grant, R.K. Heaton, J. Joseph, K. Marder, C.M. Marra, J.C. McArthur, M. Nunn, R.W. Price, L. Pulliam, K.R. Robertson, N. Sacktor, V. Valcour, and V.E. Wojna Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 2007 1789 1799
3. A. Baraniskin, J. Kuhnhenn, U. Schlegel, A. Chan, M. Deckert, R. Gold, A. Maghnouj, H. Zollner, A. Reinacher-Schick, W. Schmiegel, S.A. Hahn, and R. Schroers Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system Blood 117 2011 3140 3146
4. S.E. Beck, K.M. Kelly, S.E. Queen, R.J. Adams, M.C. Zink, P.M. Tarwater, and J.L. Mankowski Macaque species susceptibility to simian immunodeficiency virus: increased incidence of SIV central nervous system disease in pigtailed macaques versus rhesus macaques J. Neurovirol. 21 2015 148 158
5. S.J. Bissel, G. Wang, A.M. Trichel, M. Murphey-Corb, and C.A. Wiley Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis J. Neuroimmunol. 177 2006 85 98
6. D. Bonneh-Barkay, S.J. Bissel, G. Wang, K.N. Fish, G.C. Nicholl, S.W. Darko, R. Medina-Flores, M. Murphey-Corb, P.A. Rajakumar, J. Nyaundi, J.W. Mellors, R. Bowser, and C.A. Wiley YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor Am. J. Pathol. 173 2008 130 143
7. B.J. Brew, L. Pemberton, P. Cunningham, and M.G. Law Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage J. Infect. Dis. 175 1997 963 966
8. R. Brinkmann, A. Schwinn, O. Narayan, C. Zink, H.W. Kreth, W. Roggendorf, R. Dorries, S. Schwender, H. Imrich, and V. ter Meulen Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue Ann. Neurol. 31 1992 361 365
9. T.H. Burdo, M.R. Lentz, P. Autissier, A. Krishnan, E. Halpern, S. Letendre, E.S. Rosenberg, R.J. Ellis, and K.C. Williams Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy J. Infect. Dis. 204 2011 154 163
10. T.H. Burdo, A. Weiffenbach, S.P. Woods, S. Letendre, R.J. Ellis, and K.C. Williams Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection AIDS 27 2013 1387 1395
11. K.L. Burgos, A. Javaherian, R. Bomprezzi, L. Ghaffari, S. Rhodes, A. Courtright, W. Tembe, S. Kim, R. Metpally, and K. Van Keuren-Jensen Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing RNA 19 2013 712 722
12. L. Chakrabarti, M. Hurtrel, M.A. Maire, R. Vazeux, D. Dormont, L. Montagnier, and B. Hurtrel Early viral replication in the brain of SIV-infected rhesus monkeys Am. J. Pathol. 139 1991 1273 1280
13. N.K. Chauhan, M. Vajpayee, and A. Singh Usefulness of hemoglobin and albumin as prognostic markers for highly active antiretroviral therapy for HIV-1 infection Indian J. Med. Sci. 65 2011 286 296
14. J.P. Cogswell, J. Ward, I.A. Taylor, M. Waters, Y. Shi, B. Cannon, K. Kelnar, J. Kemppainen, D. Brown, C. Chen, R.K. Prinjha, J.C. Richardson, A.M. Saunders, A.D. Roses, and C.A. Richards Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways J Alzheimers Dis 14 2008 27 41
15. J. Cohen AIDS research. Vaccine studies stymied by shortage of animals Science 287 2000 959 960
16. L.A. Cysique, B.J. Brew, M. Halman, J. Catalan, N. Sacktor, R.W. Price, S. Brown, J.H. Atkinson, D.B. Clifford, D. Simpson, G. Torres, C. Hall, C. Power, K. Marder, J.C. McArthur, W. Symonds, and C. Romero Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients J. Acquir. Immune. Defic. Syndr. 39 2005 426 429
17. R.J. Ellis, K. Hsia, S.A. Spector, J.A. Nelson, R.K. Heaton, M.R. Wallace, I. Abramson, J.H. Atkinson, I. Grant, and J.A. McCutchan Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group Ann. Neurol. 42 1997 679 688
18. A. Etzerodt, and S.K. Moestrup CD163 and inflammation: biological, diagnostic, and therapeutic aspects Antioxid. Redox Signal. 18 2013 2352 2363
19. S. Fredrikson, H. Link, and P. Eneroth CSF neopterin as marker of disease activity in multiple sclerosis Acta Neurol. Scand. 75 1987 352 355
20. D. Fuchs, F. Chiodi, J. Albert, B. Asjo, L. Hagberg, A. Hausen, G. Norkrans, G. Reibnegger, E.R. Werner, and H. Wachter Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1 AIDS 3 1989 285 288
21. D.H. Gabuzda, D.D. Ho, S.M. de la Monte, M.S. Hirsch, T.R. Rota, and R.A. Sobel Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS Ann. Neurol. 20 1986 289 295
22. M. Gisslen, L. Rosengren, L. Hagberg, S.G. Deeks, and R.W. Price Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection AIDS Res. Ther. 2 2005 6
23. F. Gotch, D. Nixon, A. Gallimore, S. McAdam, and A. McMichael Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV J. Med. Primatol. 22 1993 119 123
24. L. Hagberg, P. Cinque, M. Gisslen, B.J. Brew, S. Spudich, A. Bestetti, R.W. Price, and D. Fuchs Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection AIDS Res. Ther. 7 2010 15
25. R.K. Heaton, D.B. Clifford, D.R. Franklin Jr., S.P. Woods, C. Ake, F. Vaida, R.J. Ellis, S.L. Letendre, T.D. Marcotte, J.H. Atkinson, M. Rivera-Mindt, O.R. Vigil, M.J. Taylor, A.C. Collier, C.M. Marra, B.B. Gelman, J.C. McArthur, S. Morgello, D.M. Simpson, J.A. McCutchan, I. Abramson, A. Gamst, C. Fennema-Notestine, T.L. Jernigan, J. Wong, and I. Grant HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study Neurology 75 2010 2087 2096
26. A. Kanekar Biomarkers predicting progression of human immunodeficiency virus-related disease J. Clin. Med. Res. 2 2010 55 61
27. J.D. Kowalska, A. Mocroft, A. Blaxhult, R. Colebunders, J. van Lunzen, D. Podlekareva, A.B. Hansen, L. Machala, I. Yust, and T. Benfield Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection AIDS Res. Hum. Retroviruses 23 2007 1183 1188
28. Y. Koyanagi, S. Miles, R.T. Mitsuyasu, J.E. Merrill, H.V. Vinters, and I.S. Chen Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms Science 236 1987 819 822
29. N.L. Letvin, and N.W. King Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques J. Acquir. Immune. Defic. Syndr. 3 1990 1023 1040
30. A.J. Levine, S. Service, E.N. Miller, S.M. Reynolds, E.J. Singer, P. Shapshak, E.M. Martin, N. Sacktor, J.T. Becker, L.P. Jacobson, P. Thompson, and N. Freimer Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults the official publication of the International Society of Psychiatric Genetics Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 159B 2012 669 683
31. J. Liu, J.M. Sisk, L. Gama, J.E. Clements, and K.W. Witwer Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system Mol. Brain 6 2013 40
32. J.L. Mankowski, J.E. Clements, and M.C. Zink Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model J. Infect. Dis. 186 2 2002 S199 S208
33. J.L. Mankowski, M.T. Flaherty, J.P. Spelman, D.A. Hauer, P.J. Didier, A.M. Amedee, M. Murphey-Corb, L.M. Kirstein, A. Munoz, J.E. Clements, and M.C. Zink Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence J. Virol. 71 1997 6055 6060
34. J.L. Mankowski, S.E. Queen, J.E. Clements, and M.C. Zink Cerebrospinal fluid markers that predict SIV CNS disease J. Neuroimmunol. 157 2004 66 70
35. J.L. Mankowski, S.E. Queen, C.S. Fernandez, P.M. Tarwater, J.M. Karper, R.J. Adams, and S.J. Kent Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques PLoS One 3 2008 e3603
36. J.L. Mankowski, S.E. Queen, P.M. Tarwater, K.J. Fox, and V.H. Perry Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41 J. Neuropathol. Exp. Neurol. 61 2002 85 90
37. M.C. Marcondes, C. Flynn, S. Huitron-Rezendiz, D.D. Watry, M. Zandonatti, and H.S. Fox Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys AIDS 23 2009 1187 1195
38. M.A. McAlexander, M.J. Phillips, and K.W. Witwer Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid Front. Genet. 4 2013 83
39. J.C. McArthur, N. Haughey, S. Gartner, K. Conant, C. Pardo, A. Nath, and N. Sacktor Human immunodeficiency virus-associated dementia: an evolving disease J. Neurovirol. 9 2003 205 221
40. J.C. McArthur, D.R. McClernon, M.F. Cronin, T.E. Nance-Sproson, A.J. Saah St, M. Clair, and E.R. Lanier Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann. Neurol. 42 1997 689 698
41. J.C. McArthur, M.P. McDermott, D. McClernon St, C. Hillaire, K. Conant, K. Marder, G. Schifitto, O.A. Selnes, N. Sacktor, Y. Stern, S.M. Albert, K. Kieburtz, J.A. deMarcaida, B. Cohen, and L.G. Epstein Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy Arch. Neurol. 61 2004 1687 1696
42. A. Mellgren, R.W. Price, L. Hagberg, L. Rosengren, B.J. Brew, and M. Gisslen Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection Neurology 69 2007 1536 1541
43. P. Mestdagh, N. Hartmann, L. Baeriswyl, D. Andreasen, N. Bernard, C. Chen, D. Cheo, P. D'Andrade, M. DeMayo, L. Dennis, S. Derveaux, Y. Feng, S. Fulmer-Smentek, B. Gerstmayer, J. Gouffon, C. Grimley, E. Lader, K.Y. Lee, S. Luo, P. Mouritzen, A. Narayanan, S. Patel, S. Peiffer, S. Ruberg, G. Schroth, D. Schuster, J.M. Shaffer, E.J. Shelton, S. Silveria, U. Ulmanella, V. Veeramachaneni, F. Staedtler, T. Peters, T. Guettouche, L. Wong, and J. Vandesompele Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study Nat. Methods 11 2014 809 815
44. K.A. Metcalf Pate, C.E. Lyons, J.L. Dorsey, S.E. Queen, R.J. Adams, C.N. Morrell, and J.L. Mankowski TGFbeta-mediated downregulation of thrombopoietin is associated with platelet decline in asymptomatic SIV infection J. Acquir. Immune Defic. Syndr. 65 2014 510 516
45. K.A. Metcalf Pate, C.E. Lyons, J.L. Dorsey, E.N. Shirk, S.E. Queen, R.J. Adams, L. Gama, C.N. Morrell, and J.L. Mankowski Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques J. Infect. Dis. 208 2013 874 883
46. Meulendyke, K.A., Queen, S.E., Engle, E.L., Shirk, E.N., Liu, J., Steiner, J.P., Nath, A., Tarwater, P.M., Graham, D.R., Mankowski, J.L., Zink, M.C., 2014. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. J. Neurovirol.
47. M.D. Miller, H. Yamamoto, A.L. Hughes, D.I. Watkins, and N.L. Letvin Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys J. Immunol. 147 1991 320 329
48. A. Mocroft, O. Kirk, S.E. Barton, M. Dietrich, R. Proenca, R. Colebunders, C. Pradier, A. dArminio Monforte, B. Ledergerber, and J.D. Lundgren Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group AIDS 13 1999 943 950
49. N.Z. Mothobi, and B.J. Brew Neurocognitive dysfunction in the highly active antiretroviral therapy era Curr. Opin. Infect. Dis. 25 2012 4 9
50. T. Muhl, M. Krawczak, P. Ten Haaft, G. Hunsmann, and U. Sauermann MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys J. Immunol. 169 2002 3438 3446
51. C. Murr, B. Widner, B. Wirleitner, and D. Fuchs Neopterin as a marker for immune system activation Curr. Drug Metab. 3 2002 175 187
52. E.A. Murray, D.M. Rausch, J. Lendvay, L.R. Sharer, and L.E. Eiden Cognitive and motor impairments associated with SIV infection in rhesus monkeys Science 255 1992 1246 1249
53. S. Nightingale, A. Winston, S. Letendre, B.D. Michael, J.C. McArthur, S. Khoo, and T. Solomon Controversies in HIV-associated neurocognitive disorders Lancet Neurol. 13 2014 1139 1151
54. A.K. Njamnshi, A.C. Bissek, P. Ongolo-Zogo, E.N. Tabah, A.Z. Lekoubou, F.N. Yepnjio, J.Y. Fonsah, C.T. Kuate, S.A. Angwafor, F. Dema, D.M. Njamnshi, C. Kouanfack, P. Djientcheu Vde, W.F. Muna, and G.D. Kanmogne Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon J. Neurol. Sci. 285 2009 149 153
55. D.H. O'Connor, B.R. Mothe, J.T. Weinfurter, S. Fuenger, W.M. Rehrauer, P. Jing, R.R. Rudersdorf, M.E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A.B. McDermott, T.M. Allen, C. Wang, G.G. Doxiadis, D.C. Montefiori, A. Hughes, D.R. Burton, D.B. Allison, S.M. Wolinsky, R. Bontrop, L.J. Picker, and D.I. Watkins Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses J. Virol. 77 2003 9029 9040
56. M. Pacifici, S. Delbue, P. Ferrante, D. Jeansonne, F. Kadri, S. Nelson, C. Velasco-Gonzalez, J. Zabaleta, and F. Peruzzi Cerebrospinal fluid miRNA profile in HIV-encephalitis J. Cell. Physiol. 228 2013 1070 1075
57. R. Pal, D. Venzon, N.L. Letvin, S. Santra, D.C. Montefiori, N.R. Miller, E. Tryniszewska, M.G. Lewis, T.C. VanCott, V. Hirsch, R. Woodward, A. Gibson, M. Grace, E. Dobratz, P.D. Markham, Z. Hel, J. Nacsa, M. Klein, J. Tartaglia, and G. Franchini ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A∗LVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibi J. Virol. 76 2002 292 302
58. I. Pandrea, E. Cornell, C. Wilson, R.M. Ribeiro, D. Ma, J. Kristoff, C. Xu, G.S. Haret-Richter, A. Trichel, C. Apetrei, A. Landay, and R. Tracy Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates Blood 120 2012 1357 1366
59. M.R. Pranzatelli, E.D. Tate, N.R. McGee, and S.J. Verhulst CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders J. Neuroimmunol. 266 2014 75 81
60. C.C. Pritchard, H.H. Cheng, and M. Tewari MicroRNA profiling: approaches and considerations Nat. Rev. Genet. 13 2012 358 369
61. L. Pulliam, R. Gascon, M. Stubblebine, D. McGuire, and M.S. McGrath Unique monocyte subset in patients with AIDS dementia Lancet 349 1997 692 695
62. S.E. Queen, B.M. Mears, K.M. Kelly, J.L. Dorsey, Z. Liao, J.B. Dinoso, L. Gama, R.J. Adams, M.C. Zink, J.E. Clements, S.J. Kent, and J.L. Mankowski Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques J. Virol. 85 2011 9167 9175
63. A.B. Ragin, G. D'Souza, S. Reynolds, E. Miller, N. Sacktor, O.A. Selnes, E. Martin, B.R. Visscher, and J.T. Becker Platelet decline as a predictor of brain injury in HIV infection J. neurovirol. 17 2011 487 495
64. G. Raposo, and W. Stoorvogel Extracellular vesicles: exosomes, microvesicles, and friends J. Cell Biol. 200 2013 373 383
65. E.M. Ratai, S. Pilkenton, J. He, R. Fell, J.P. Bombardier, C.G. Joo, M.R. Lentz, W.K. Kim, T.H. Burdo, P. Autissier, L. Annamalai, E. Curran, S.P. O'Neil, S.V. Westmoreland, K.C. Williams, E. Masliah, and R. Gilberto Gonzalez CD8+ lymphocyte depletion without SIV infection does not produce metabolic changes or pathological abnormalities in the rhesus macaque brain J. Med. Primatol. 40 2011 300 309
66. R. Reynoso, N. Laufer, M. Hackl, S. Skalicky, R. Monteforte, G. Turk, M. Carobene, J. Quarleri, P. Cahn, R. Werner, H. Stoiber, R. Grillari-Voglauer, and J. Grillari MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro Sci. Rep. 4 2014 5915
67. S. Rom, I. Rom, G. Passiatore, M. Pacifici, S. Radhakrishnan, L. Del Valle, S. Pina-Oviedo, K. Khalili, D. Eletto, and F. Peruzzi CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells FASEB J. 24 2010 2292 2300
68. S. Sanchez-Ramon, J.M. Bellon, S. Resino, C. Canto-Nogues, D. Gurbindo, J.T. Ramos, and M.A. Munoz-Fernandez Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children Pediatrics 111 2003 E168 E175
69. U. Sauermann Making the animal model for AIDS research more precise: the impact of major histocompatibility complex (MHC) genes on pathogenesis and disease progression in SIV-infected monkeys Curr. Mol. Med. 1 2001 515 522
70. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, J. Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber, N.L. Letvin, and K.A. Reimann Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 1999 857 860
71. J.J. Sevigny, S.M. Albert, M.P. McDermott, J.C. McArthur, N. Sacktor, K. Conant, G. Schifitto, O.A. Selnes, Y. Stern, D.R. McClernon, D. Palumbo, K. Kieburtz, G. Riggs, B. Cohen, L.G. Epstein, and K. Marder Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia Neurology 63 2004 2084 2090
72. Sharer, L.R., Baskin, G.B., Cho, E.S., Murphey-Corb, M., Blumberg, B.M., Epstein, L.G., 1988. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann. Neurol. 23 Suppl, S108-112.
73. J.M. Sisk, K.W. Witwer, P.M. Tarwater, and J.E. Clements SIV replication is directly downregulated by four antiviral miRNAs Retrovirology 10 2013 95
74. M.Z. Smith, C.J. Dale, R. De Rose, I. Stratov, C.S. Fernandez, A.G. Brooks, J. Weinfurter, K. Krebs, C. Riek, D.I. Watkins, D. O'Connor, and H. Kent, S.J. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes J. Virol. 79 2005 684 695
75. M.Z. Smith, C.S. Fernandez, A. Chung, C.J. Dale, R. De Rose, J. Lin, A.G. Brooks, K.C. Krebs, D.I. Watkins, D.H. O'Connor, M.P. Davenport, and S.J. Kent The pigtail macaque MHC class I allele Mane-A∗he pigtail macaque MHC class I allel epitope: identification, tetramer development and implications of immune escape and reversion J. Med. Primatol. 34 2005 282 293
76. Y.M. Sun, K.Y. Lin, and Y.Q. Chen Diverse functions of miR-125 family in different cell contexts J. Hematol. Oncol. 6 2013 6
77. G. Swaminathan, S. Navas-Martin, and J. Martin-Garcia MicroRNAs and HIV-1 infection: antiviral activities and beyond J. Mol. Biol. 426 2014 1178 1197
78. K.I. Tasca, S.A. Calvi, and R. Souza Ldo Immunovirological parameters and cytokines in HIV infection Rev. Soc. Bras. Med. Trop. 45 2012 663 669
79. K.A. Thompson, S.J. Kent, M.E. Gahan, D.F. Purcell, C.A. McLean, S. Preiss, C.J. Dale, and S.L. Wesselingh Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus J. Neurovirol. 9 2003 442 451
80. R. Tortelli, M. Copetti, M. Ruggieri, R. Cortese, R. Capozzo, A. Leo, E. D'Errico, M. Mastrapasqua, S. Zoccolella, F. Pellegrini, I.L. Simone, and G. Logroscino Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis the official journal of the European Federation of Neurological Societies Eur. J. Neurol. 2014
81. R. Tortelli, M. Ruggieri, R. Cortese, E. D'Errico, R. Capozzo, A. Leo, M. Mastrapasqua, S. Zoccolella, R. Leante, P. Livrea, G. Logroscino, and I.L. Simone Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression the official journal of the European Federation of Neurological Societies Eur. J. Neurol. 19 2012 1561 1567
82. J.J. van Eijk, B. van Everbroeck, W.F. Abdo, B.P. Kremer, and M.M. Verbeek CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease J. Alzheimer's Dis.: JAD 21 2010 569 576
83. L.M. Wachtman, P.M. Tarwater, S.E. Queen, R.J. Adams, and J.L. Mankowski Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease J. Neurovirol. 12 2006 25 33
84. A.K. Watson, and K.W. Witwer Do platform-specific factors explain microRNA profiling disparities? Clin. Chem. 2011
85. M.R. Weed, R.D. Hienz, J.V. Brady, R.J. Adams, J.L. Mankowski, J.E. Clements, and M.C. Zink Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection J. Neurovirol. 9 2003 452 464
86. D.W. Williams, E.A. Eugenin, T.M. Calderon, and J.W. Berman Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis J. Leukocyte Biol. 91 2012 401 415
87. K. Williams, and T.H. Burdo Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans the official journal of the Society on NeuroImmune Pharmacology J. Neuroimmune Pharmacol. 7 2012 363 371
88. R. Williams, S. Bokhari, P. Silverstein, D. Pinson, A. Kumar, and S. Buch Nonhuman primate models of NeuroAIDS J. Neurovirol. 14 2008 292 300
89. A. Winston, C. Duncombe, P.C. Li, J.M. Gill, S.J. Kerr, R. Puls, K. Petoumenos, S.D. Taylor-Robinson, S. Emery, and D.A. Cooper Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study an official publication of the Infectious Diseases Society of America Clin. Infect. Dis. 50 2010 920 929
90. K.W. Witwer Circulating microRNA biomarker studies: pitfalls and potential solutions Clin. Chem. 2014
91. K.W. Witwer, L. Gama, M. Li, C.M. Bartizal, S.E. Queen, J.J. Varrone, A.K. Brice, D.R. Graham, P.M. Tarwater, J.L. Mankowski, M.C. Zink, and J.E. Clements Coordinated regulation of SIV replication and immune responses in the CNS PLoS One 4 2009 e8129
92. K.W. Witwer, S.L. Sarbanes, J. Liu, and J.E. Clements A plasma microRNA signature of acute lentiviral infection: biomarkers of CNS disease AIDS 204 2011 1104 1114
93. L.J. Yant, T.C. Friedrich, R.C. Johnson, G.E. May, N.J. Maness, A.M. Enz, J.D. Lifson, D.H. O'Connor, M. Carrington, and D.I. Watkins The high-frequency major histocompatibility complex class I allele Mamu-B∗he high-frequency major histocompatibiliimmunodeficiency virus SIVmac239 replication J. Virol. 80 2006 5074 5077
94. A. Yilmaz, C.T. Yiannoutsos, D. Fuchs, R.W. Price, K. Crozier, L. Hagberg, S. Spudich, and M. Gisslen Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy J. Neuroinflammation 10 2013 62
95. M.C. Zink, A.M. Amedee, J.L. Mankowski, L. Craig, P. Didier, D.L. Carter, A. Munoz, M. Murphey-Corb, and J.E. Clements Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol. 151 1997 793 803
96. M.C. Zink, G.D. Coleman, J.L. Mankowski, R.J. Adams, P.M. Tarwater, K. Fox, and J.E. Clements Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis J. Infect. Dis. 184 2001 1015 1021
97. M.C. Zink, K. Suryanarayana, J.L. Mankowski, A. Shen, M. Piatak Jr., J.P. Spelman, D.L. Carter, R.J. Adams, J.D. Lifson, and J.E. Clements High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis J. Virol. 73 1999 10480 10488
98. A. Zoufaly, J.G. Kiepe, S. Hertling, A. Hufner, O. Degen, T. Feldt, S. Schmiedel, M. Kurowski, and J. van Lunzen Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals HIV Med. 15 2014 449 457